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1. Introduction 
Periodontal disease is a common gum disorder thought to 
affect about 80% of the population in many countries.1 It is an 
inflammatory disease caused by various species of dental plaque 
bacteria and symptoms vary from mild gingivitis to severe 
alveolar pyorrhea. Recent studies indicated that the progress of 
the disease cause a systemic illness through blood vessels 
infected by bacteria from periodontal tissues. 2 Consequently, 
early detection and treatments are required for improvements in 
the quality of life (QOL). However examination methods for 
periodontal disease have not been established. Currently 
diagnosis for this disease relies predominantly on the judgment 
of a dentist through examination of periodontal pocket and 
confirmation of bleeding from periodontal tissue. Current 
methods are not entirely reliable as it depends on the skill of the 
dentists, hence an objective and facile examination method is 
necessary. Conventional biodetection involves the discovery of 
distinct targets responsible for the disease and mostly involve 
applications of “antigen-antibody” interactions.3-5 Such detection 
of known substances is based on "one to one" recognition, while 
detection of disease-related substances, unknown targets and/or 
surrogate markers is difficult. During the last decade 
considerable efforts have been devoted to the development of a 
novel biodetection system using labelled structured peptides, 
arrayed on a chip surface. In fact proteins consist of different 
amino acids with post-translational modifications and exhibit 
structures containing α-helices, β-sheets and β-loops. Protein-
protein interactions can be mimicked by protein-peptides in 
which the peptides have the appropriate structures. The structural 
changes of the protein as an analyte are reflected in the 
fluorescent-intensity changes of peptides as capture molecules in 
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early detection with treatment is desirable for the improvement of the quality of life. 
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required. We have performed an experiment on saliva using a novel biodetection system, 
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classification of the type of proteins added in saliva as mimetics of disease. PepTenChip® 
system is useful and convenient for examination of periodontal disease in health care. 











a dose dependent manner and are converted to a color bar-code, 
designated a “PFP” for visualization. 6-9 There are four major 
fundamental technologies which have been completed recently: 
those are (1) capture molecules, fluorescent labelled structured 
peptides libraries has been constructed, 7, 8 (2) chip plates, a novel 
material made from amorphous carbon, 10  (3) arraying 
technology (deposition of a few pico-litres), several methods 
including printing by piezo elements have been employed which 
showed low throughput. Pin-deposition was the most reliable 
with regard to cost, reproducibility and throughput, and (4) 
fluorescent detection, small and maintenance free device suitable 
for use in biosafety level 3 and 4 rooms has been constructed. 
The present biodetection chip, designated PepTenChip®, allows 
minimization of the amounts of both analytes (nano gram) and 
capture molecules (several femto mole). 9, 11 In the present study 
these four technologies have been applied to saliva as analyte. 
Proteins, f-Hb and LDH, were used as a blood marker and a cell 
damage marker, respectively. The present analyses were carried 
out using labelled structured peptides as capture molecules and 
analytes, which served as a disease model of saliva containing 
with or without hemoglobin (f-Hb) and lactate dehydrogenase 
(LDH).12 Additionally data handling by the statistical methods are 
also described. 
2. Materials and Methods 
2.1. General 
The major reagents for peptide syntheses, amino acid 
derivatives, solid supports (TentaGel® S RAM, Rapp Polymere 
GmbH, Tuebingen, Germany), (2-(1H-benzotriazole-1-yl)-
1,1,3,3-tetramethylaminium hexafluorophosphate (HBTU), 1-
hydroxybenzotriazole (HOBt) and tetramethylrhodamine 
(TAMRA) were from HiPep Laboratories (Kyoto, Japan). Other 
reagents and solvents were purchased from Nacalai Tesque Inc. 
(Kyoto, Japan) and used as received. Water was prepared by a 
Milli-Q apparatus (Millipore, Tokyo, Japan). On-line LC-MS 
was used for quality assessment of peptides used in this study. 
Peptide solutions were prepared in a 384-well microtiter plate 
(Thermo Fisher Scientific K.K., Kanagawa, Japan). Marker 
protein for periodontal disease was purchased from Sigma-
Ardrich Japan K.K. (Tokyo, Japan). 
2.2. Synthesis of designed fluorescence labelled peptide for 
capture molecules 
Structured peptide libraries used in the present study have 
been previously reported.7, 8 Briefly the assembly was performed 
using automated synthesizers, PSSM-8 (Shimadzu Corp., Kyoto, 
Japan) and PetiSyzer®s (HiPep Laboratories) by the Fmoc solid-
phase strategy and cleaved from resin. Each peptide has been 
characterized by LC (LC20A, Shimadzu Corp.)-ITMS (HCTultra, 
Bruker Japan K.K., Kanagawa, Japan) system on HiPep-Cadenza 
(3.0 i.d. × 150 mm, HiPep Laboratories) after purification on 
preparative scale columns (50 mm i.d. x 250 mm, HiPep 
Laboratories). Several peptides having difficult sequences could 
be obtained in higher yield by coupling at elevated temperature.13 
The peptides for arraying were dissolved in 1,1,1,3,3,3-
hexafluoro-2-propanol (HFIP, Nacalai Tesque inc.) and stored at 
-80°C until arraying. The sequence of designed peptides are 
listed in Electronical Supplemental Information Table S1. 
2.3. Derivatization of amorphous carbon substrate  
A carboxyl PepTenChip® (PTC-CA-NN-02, HiPep 
Laboratories) 14 was derivatized with 6-maleimide caproic acid 
(EMCA, HiPep Laboratories) by the following procedures. 
Firstly, the substrate was placed in a reaction vessel for chips 
(Pap jars, Evergreen Scientific, CA, USA) and 10 mM N,N’-
diisopropylcarbodiimide (DIPCDI, Sigma-Aldrich Japan K.K.) 
and 10 mM N-hydroxysuccinimide (NHS) dissolved in DMF 
were added and incubated at room temperature for 1 h. To the 
resulting mixture 10 mM hexamethylene diamine (Nacalai 
Tesque Inc.) dissolved in DMF was added and gently stirred at 
room temp for 1 h, washed 5 times with methanol and dried in 
vacuo. The chip-surface was thus aminated. A solution of 20 mM 
EMCA and 10 mM DIPCDI in DCM was prepared in 
LibraTube® RT5M (HiPep Laboratories) and shaken at room 
temperature for 1 h. After removal of white precipitates by 
filtration the liquor was added to the above Pap jar, diluted with 
DCM (30 mL) and pyridine was added (10 mM). The resulted 
mixture was shaken at room temperature for 1 h, washed with 5 
times with methanol and dried in vacuo. 
2.4. Preparation of Peptide microarray 
A solution of synthetic peptides (100 µM) for capturing in 
HFIP with 1% acetic acid was dispensed on to a 384 well 
microtiter plate and arrayed using a microarrayer 
(NanoPrint(TM) LM-60) with a printing pin14 (946MP4, spot 
diameter 135 µm) manufactured by Arrayit Corp., CA, USA). 
After arraying, the chip-plate was washed three times with 2-
mercaptoethanol (10 mM) and ultrapure water. After spin drying, 
the substrate was analyzed with a fluorescence detector (PTC-FD 
11, HiPep Laboratories) to confirm desired array quality. The 
resulting PepTenChip®s allow continuous detection of 
fluorescence intensity changes of the chip surface.  
2.5. Detection of saliva sample 
Saliva from healthy and disease models, which are the mixture 
of disease marker proteins, were applied on the substrates. Hence 
10 μL of PBS (Phosphate Buffered Saline, pH 7.0) was applied 
as blank. The drop of samples were spread using cover glass (18 
x 18 mm, Matsunami Glass Ind., Ltd., Osaka, Japan) and 
incubated at ambient temperature for 30 min in the dark. After 30 
min the fluorescence intensity of the microarray was measured 
using a fluorescence detection device (PTC-FD 11) and it was 
defined as I0. Fluorescence images obtained in the assay were 
quantified using the image analysis software Array-pro(TM) 
Analyzer (Nippon Roper K. K., Tokyo, Japan). After measuring 
I0, the cover glass was removed from the substrate, washed three 
times with 2-mercaptoethanol solution and ultrapure water, spin-
dried, and assayed for the specimens. The assay of the specimen 
was performed in the same manner as the detection of PBS, and 
the resulting fluorescence intensity was set to I1. After assays, 
the fluorescence intensity changes were calculated according to 
the following equation. The fluorescence intensity changes were 
subjected to various statistical analyses. 
Fluorescent intensity change= (I1 - I0) / I0  
2.6. Statistical Analysis 
For statistical analyses, peptide-probes which showed 
fluorescence intensity dependent on concentration of marker 
proteins were selected by the RSQ function of Microsoft® 
Excel®2013. In this procedure, a total of 20 peptides were 
selected from 500 peptides as these showed significant intensity 
changes. PFP was prepared using the program for statistical 
analysis, R ver. 3.2.1. Furthermore, dendrogram were created by 
clustering Euclidean squared distances and Ward's method from 
the results of PFP. 
3. Results and Discussions 
3.1. Peptide Microarray  
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in this study, (b) Arrangement of arrayed peptides.Fig. 1 Design of 
synthetic peptides. (a) A schematic diagram of the fluorescent labelled 
peptide on a substrate, (b) Design of peptides with α-helix structure. A 
random amphipathic peptide library was constructed by adding 
hydrophobic amino acids to X and hydrophilic amino acids to Y, (c) 
Schematic drawing of labelled peptide. 
Labelled peptide libraries having α-helical structures used as 
capture molecules have been constructed by solid phase synthesis, 
purified and their secondary structures have been confirmed by 
CD spectra. 4, 5 Peptide design is illustrated in Fig. 1 where the 
fluorescent dye was TAMRA, Gly was used as a spacer and the 
Cys residue was for immobilization on to chip surface using 
EMCA. Five hundred different peptides were arrayed on an 
amorphous carbon plates using a micro-arrayer with a pin-system, 
946MP4, as described in the experimental section. The spot 
diameter was 135 µm and amounts of applied peptide solution 
was ca. 1.1 nL/spot (Fig. 2). The microarrays have been prepared 
as described in the experimental section. Peptides which change 
their fluorescent intensity depending on the concentration of 
proteins in the analyte have been selected from 500 structured 
peptides in the library, that is, those selected peptides interacted 
with proteins (f-Hb and LDH). Table 1 shows the list of 
specimens and concentration of proteins used in this assay. Saliva 























Analysis of Variance (ANOVA) was performed in order to test 
whether there was a significant difference in data obtained by the 
assay. ANOVA results are indicated in Table 3. Comparing the F 
value (F, 8.367) calculated in this ANOVA analysis with the F 
value (F0.01, 8.3967, Electronical Supplemental Information 
Table S4) in the F distribution table, F0.01 <F. Therefore, we 
concluded that there was a difference in the fluorescence 
intensity change value at the 1% significance level. In addition, 
the P value (P value in Table 3) was 7.34e-5, which was a very 
small value. From these two results, it was judged that the data 
obtained in this study was significantly different at P = 0.01. In f-
Hb data, peptides with strongly changing fluorescence intensity 
were found when f-Hb concentration reaches 100 μg/mL (Fig. 
3a). In particular, peptide No. 202, 203, 204, 205, 213, 215 show 
marked changes and are considered to be useful capture peptides 
which interact with hemoglobin. In the case of LDH, peptides 
were found in which the fluorescence intensity varied with the 
protein concentration (Fig. 3b). In particular, peptide No. 203, 
204, 279, 319 generate remarkable fluorescence intensity change 
by LDH concentration, and are judged to be useful for detection 
of LDH. Hence peptide No. 203 and 204 were also selected from 
f-Hb data, thus they interact with both f-Hb and LDH. 
Table 1. The list of specimens using this study.  
Sample name Sample content 
S Saliva only 
Hb0.5 Saliva + f-Hb 0.5 µg/mL 
Hb1.0 Saliva + f-Hb 1.0 µg/mL 
Hb10 Saliva + f-Hb 10 µg/mL 
Hb100 Saliva + f-Hb 100 µg/mL 
L10 Saliva + LDH 10 mU/mL 
L70 Saliva + LDH 70 mU/mL 
L100 Saliva + LDH 100 mU/mL 
L1000 Saliva + LDH 1000 mU/mL 
HL Saliva + f-Hb 1.0 µg/mL + LDH 100 mU/mL 
aThe sample name Hb1.0, Hb10, L10, L100, and L1000 are used for selection 
of peptides in which protein concentration dependent fluorescence intensity 
change. Hb0.5, Hb1.0, L70, L100 and HL are concentrations actually used for 
saliva analyses in dental clinic. (n=3 results). Concentration of f-Hb and LDH 
are conventionally used in the field of dental diagnosis to discriminate 
positive and negative in periodontal disease.12 
Table 2. Comparison of properties of peptides classified by PFP. 
aI. P. is Isoelectric Point, and H. I. is Hydrophobicity Index. 
 
3.2. Selection of peptides that interact with proteins 
The correlation coefficient was calculated from the 
fluorescence intensity change obtained by the assay for each 
protein using the RSQ function of Microsoft(R) Excel(R) 2013 
(in Electronical Supplemental Information Tables S2, S3). The 
20-peptides were selected (Table 2) in descending order of the 
correlation coefficients calculated by RSQ function (in 
Electronical Supplemental Information Table S3, S4) and the 
change in fluorescence intensity was compared (Fig. 3). 
Peptide# Seq. (α-TAMRA-G-XXXX-GC-NH2) Mwt. I.P. H.I. 
202 FQQ FFK FFQ QFF KF 1964.3 10.3 0.04 
203 LQQ FFK FLQ QFF KF 1896.3 10.31 0.19 
204 LQQ LFK FLQ QLF KF 1828.2 10.31 0.33 
205 LQQ LLK FLQ QLL KF 1760.2 10.31 0.47 
206 FKK FFS FFK KFF SF 1882.3 10.3 0.37 
213 LSS LLK FLK KLL SF 1637.1 10.6 1.02 
214 FSS FFK FFS SFF KF 1800.1 10.3 0.81 
215 LSS FFK FLS SFF KF 1732.1 10.31 0.96 
237 LQQ LLR FLR RLL QF 1844.3 12.8 0.31 
279 LSS LLK VLK KLL SV 1541 10.6 1.22 
287 LEE LLR VLE ELL RV 1724 4.52 0.59 
319 AQQ AAK IAK KAA QI 1439.7 10.6 -0.17 
332 AEE AIR IAE EAI RI 1583.8 4.52 0.16 
352 AKK FFR FAK KFF RF 1868.3 12.52 -0.3 
354 AKK AAR FAK KAA RF 1563.9 12.52 -0.59 
380 AKK AFS FAK KAF SF 1577.9 10.3 0.09 
400 AQQ FFR FAR RFF QF 1896.2 12.8 -0.26 
449 ARR AVQ VAR RAV QV 1579.9 12.98 -0.07 
452 AQQ AAR VAR RAA QV 1495.7 12.8 -0.34 
498 IQQ IFR FIR RIF QF 1912.3 12.8 0.37 
Fig. 2. The microarray prepared in the present study. An amino-amorphous 
carbon plate (25 x 75 mm) has three blocks of derivatized area and 500 



































Table 3. Outline of Analysis of Variance conducted on fluorescence intensity change. 
 Degree of freedom Sum of squares Mean square F value P value 
Between groups 5 1.013 0.20268 5.866 7.34e-5 
Within group 114 3.939 0.03455   
aDegree of freedom (between groups) = number of groups – 1 = 6 – 1, Degree of freedom (within group) = (data number within group – 1) x number of 
groups = (20 – 1) x 6. 
Fig. 3 Comparison of changes in fluorescence intensity with respect to protein concentration. Fluorescence intensity change, (a): specimen is f-
Hb; (b): specimen is LDH. 
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3.3. PFPs and Dendrogram 
Fig. 4 shows PFP prepared from values in the 
fluorescence intensity changes. The red and green color 
indicate higher and lower value of the changes, respectively. 
Hence LDH increases intensity with many peptides. The 
above selected 20 peptides can be classified into two groups 
by the PFP analysis with the value of fluorescence intensity 
change. The peptides were classified into two groups and 
their sequences are compared (Table 2). The average 
Hydrophobicity Index (H.I.) of the Peptide of Group 1 was 
0.15 and the average H.I. of the peptide of Group 2 was 0.35, 
and the peptides in Group 2 were slightly more hydrophobic. 
Also, fluorescence intensity change of peptide 206 and 352 
indicate marked increments in the assay with specimens. 
Both peptides consist of a lot of Lys- and Phe-residues, thus 
these amino acids are considered to play a key role for 
interaction. Phe-rich peptides classified in Group 1 increase 
fluorescence intensity change (Fig. 4), suggesting that Phe-
residue plays an important role for interaction with proteins. 
A further dendrogram was created based on the results of the 
PFP. In the dendrogram, the distance between each specimen 
is close, that is, the specimens are similar in height and 
connection of each branch. For the dendrogram obtained in 
this study, dividing a branch with a height of 20 can be 
classified into two clusters (Fig. 5). Cluster A in Fig. 5 
contains LDH and another cluster B in Fig. 5 contains f-Hb. 
Since the cluster A contains HL (mixture of f-Hb and LDH), 































Fig. 4 PFP prepared from fluorescence intensity change of selected 20 fluorescent labelled peptides. Red indicates increase in fluorescence intensity 
and green indicates decrease in fluorescence intensity. 
Fig. 5. A dendrogram created from PFP. When divided by height 20, the dendrogram are classified in two clusters (A, B). 
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3.4. Principal Component Analysis (PCA) 
Principal component analysis of the selected peptides is 
shown in Fig. 6a. The model protein samples are classified in 
the first principal component axis (PC1), and the saliva 
specimens on the second principal component axis (PC2). In 
PC1 samples containing f-Hb (Hb 0.5, Hb 1.0) were negative 
in contrast to those containing LDH (L70, L100) which were 
positive. The PC2 specimen of healthy saliva (S) was clearly 
classified as positive. In contrast saliva specimens containing 
the present model proteins (Hb 0.5, Hb 1.0, L 70, L 100, HL) 
were negative. These results show that each specimen can be 
classified from fluorescence intensity change of labeled 
peptides as capture molecules. Fig. 6b and 6c show the main 
component loading amounts and characteristic amino acids in 
each peptide. In PC1 increasing the number of Phe residues 
tends to increase of principal component loading amounts 
(Fig. 6b). For PC2 increased charged resulted in increasing 
loading (Fig. 6b). Thus, hydrophobic interaction of the 
aromatic ring of the Phe residue and electrostatic interactions 
by charged amino acids have a significant influences for the 
detection of saliva. It is expected that PepTenChip®s arrayed 

































Figure 6. (a) PCA-results. Corresponding peptide location indicated with * ; (b) Principal component loading amounts in PC1 and number of Phe-




Microarrays with structured and labelled peptides in 
combination with statistical analysis (multivariate analysis) are 
very useful to discriminate specimens between healthy and 
disease subjects containing numerous compounds. The present 
study indicates that saliva can be analysed by the PepTenChip® 
technology using a novel concept that does not rely on “one to 
one” recognition. Detection of healthy saliva contained proteins 
used as periodontal disease markers as a model specimens have 
been analysed. PepTenChip® system generated PFP-patterns with 
fluorescent intensity change between the chip (peptide array) and 
the chip with analytes. In the present study 500 different 
designed structured peptides carrying fluorescent dye were 
arrayed onto derivatized substrates, PepTenChip®, made from 
amorphous carbon. Peptides which showed significant 
fluorescence intensity change depending on the concentration of 
model proteins in saliva were selected and multivariate analyses 
allowed classification of the proteins mixed with saliva and their 
concentration. The present microarray is useful for analyses of 
biological samples, in particular, biochips arrayed with a large 
number of different structured peptides are suitable for 
comprehensive analyses involving unknown markers. The array 
with selected interacted peptides can be used for target specific 
biodetection tools. 16-18 In addition, PepTenChip® is also a very 
powerful tool for searching for novel markers contained in the 
samples. The PepTenChip® can be used as a sample tray for 
MALDI-TOF-MS analyses to directly captured proteins on the 
surface, 19, 20 allowing further characterization of their molecular 
weight and partial amino acid sequences. Following to the 
present study we are planning experiments using patient saliva to 
provide the beneficial tool for dentists. A more accurate 
diagnostics may be accomplished using databases for targeted 
disease. Additionally different body fluids, such as blood, urine 
and spinal fluid will be collected in clinics under the ethical 
approval and applied to the present system, which is a class 1 
medical device. 
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